Cabozantinib and Nivolumab for Carcinoid Tumors

Clinical trial NCT04197310 · COMPLETED

Trial details

NCT number: NCT04197310
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoid Tumor Carcinoid Tumor of GI System Neuroendocrine Tumors

Start date: 2019-12-26
Primary completion: 2023-12-27
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.